|
Schuldberg, D; Quinlan, D M; Glazer, W (1999) Positive and negative symptoms and and adjustment in severely mentally ill outpatients. Psychiatry Res 85:177-88
|
|
Morgenstern, H; Glazer, W M; Doucette, J T (1996) Handedness and the risk of tardive dyskinesia. Biol Psychiatry 40:35-42
|
|
Quinlan, D M; Schuldberg, D; Morgenstern, H et al. (1995) Positive and negative symptom course in chronic community-based patients. A two-year prospective study. Br J Psychiatry 166:634-41
|
|
Glazer, W M; Morgenstern, H; Doucette, J (1994) Race and tardive dyskinesia among outpatients at a CMHC. Hosp Community Psychiatry 45:38-42
|
|
Ziedonis, D M; Kosten, T R; Glazer, W M et al. (1994) Nicotine dependence and schizophrenia. Hosp Community Psychiatry 45:204-6
|
|
Morgenstern, H; Glazer, W M (1993) Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Arch Gen Psychiatry 50:723-33
|
|
Glazer, W M; Kane, J M (1992) Depot neuroleptic therapy: an underutilized treatment option. J Clin Psychiatry 53:426-33
|
|
Glazer, W M; Morgenstern, H; Niedzwiecki, D et al. (1988) Heterogeneity of tardive dyskinesia. A multivariate analysis. Br J Psychiatry 152:253-9
|
|
Morgenstern, H; Glazer, W M; Gibowski, L D et al. (1987) Predictors of tardive dyskinesia: results of a cross-sectional study in an outpatient population. J Chronic Dis 40:319-27
|
